{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:25:17Z","timestamp":1761488717449},"reference-count":44,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.vaccine.2011.06.025","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T14:08:30Z","timestamp":1309183710000},"page":"6049-6058","source":"Crossref","is-referenced-by-count":16,"title":["Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates"],"prefix":"10.1016","volume":"29","author":[{"given":"Jane W.","family":"Marsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Shutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Pajon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Tulenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary A.","family":"Hollick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Kiehlbauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard W.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee H.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (Suppl. 2)","key":"10.1016\/j.vaccine.2011.06.025_bib0005","doi-asserted-by":"crossref","first-page":"B51","DOI":"10.1016\/j.vaccine.2009.04.063","article-title":"Global epidemiology of meningococcal disease","volume":"27","author":"Harrison","year":"2009","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.06.025_bib0010","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J Immunol"},{"issue":"August (8346)","key":"10.1016\/j.vaccine.2011.06.025_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"issue":"March (Suppl. 2)","key":"10.1016\/j.vaccine.2011.06.025_bib0020","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines","volume":"50","author":"Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.06.025_bib0025","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.06.025_bib0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.06.025_bib0035","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J Immunol"},{"issue":"September (Pt 9)","key":"10.1016\/j.vaccine.2011.06.025_bib0040","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1099\/mic.0.029876-0","article-title":"The modular architecture of meningococcal factor H-binding protein","volume":"155","author":"Beernink","year":"2009","journal-title":"Microbiology"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.06.025_bib0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3201\/eid1004.030247","article-title":"PorA variable regions of Neisseria meningitidis","volume":"10","author":"Russell","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.06.025_bib0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"August (8814)","key":"10.1016\/j.vaccine.2011.06.025_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0140-6736(92)92411-8","article-title":"\u201cHerd immunity\u201d and the meningococcal vaccine trial in Norway","volume":"340","author":"Bjune","year":"1992","journal-title":"Lancet"},{"issue":"June (9)","key":"10.1016\/j.vaccine.2011.06.025_bib0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile, Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.06.025_bib0065","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1017\/S0950268807009211","article-title":"Combined administration of serogroup B meningococcal vaccine and conjugated serogroup C meningococcal vaccine is safe and immunogenic in college students","volume":"136","author":"Holmes","year":"2008","journal-title":"Epidemiol Infect"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.06.025_bib0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/514232","article-title":"Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland","volume":"177","author":"Perkins","year":"1998","journal-title":"J Infect Dis"},{"issue":"July (29)","key":"10.1016\/j.vaccine.2011.06.025_bib0075","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2011.06.025_bib0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2011.06.025_bib0085","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.vaccine.2009.12.082","article-title":"Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection","volume":"28","author":"Seib","year":"2010","journal-title":"Vaccine"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2011.06.025_bib0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2010.12.039","article-title":"A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression","volume":"29","author":"Keiser","year":"2011","journal-title":"Vaccine"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.06.025_bib0095","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1086\/374740","article-title":"Genetic basis for nongroupable Neisseria meningitidis","volume":"187","author":"Dolan-Livengood","year":"2003","journal-title":"J Infect Dis"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.06.025_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/341067","article-title":"Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease","volume":"186","author":"Kellerman","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.025_bib0105","series-title":"16th International pathogenic neissera conference","article-title":"The effect of quadrivalent (A, C, Y,W-135) meningococcal conjugate vaccine on serogroup-specific carriage of Neisseria meningitidis","author":"Clark","year":"2008"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.06.025_bib0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1128\/JCM.42.1.320-328.2004","article-title":"Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis","volume":"42","author":"Mothershed","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"January\u2013February (1)","key":"10.1016\/j.vaccine.2011.06.025_bib0115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3201\/eid0701.010114","article-title":"Active bacterial core surveillance of the emerging infections program network","volume":"7","author":"Schuchat","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"May","key":"10.1016\/j.vaccine.2011.06.025_bib0120","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.06.025_bib0125","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/501371","article-title":"Antigenic shift and increased incidence of meningococcal disease","volume":"193","author":"Harrison","year":"2006","journal-title":"J Infect Dis"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2011.06.025_bib0130","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1086\/651505","article-title":"Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era\u2014United States, 2000\u20132005","volume":"201","author":"Harrison","year":"2010","journal-title":"J Infect Dis"},{"issue":"July (Web Server issue)","key":"10.1016\/j.vaccine.2011.06.025_bib0135","doi-asserted-by":"crossref","first-page":"W606","DOI":"10.1093\/nar\/gkp288","article-title":"Meningococcus genome informatics platform: a system for analyzing multilocus sequence typing data","volume":"37","author":"Katz","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.06.025_bib0140","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1099\/mic.0.027995-0","article-title":"Variation of the factor H-binding protein of Neisseria meningitidis","volume":"155","author":"Brehony","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2011.06.025_bib0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2307\/2281536","article-title":"Measures of association for cross classifications","volume":"49","author":"Goodman","year":"1954","journal-title":"J Am Stat Assoc"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.06.025_bib0150","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2011.06.025_bib0155","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1534\/genetics.105.044917","article-title":"Estimating diversifying selection and functional constraint in the presence of recombination","volume":"172","author":"Wilson","year":"2006","journal-title":"Genetics"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.06.025_bib0160","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/molbev\/msj030","article-title":"Application of phylogenetic networks in evolutionary studies","volume":"23","author":"Huson","year":"2006","journal-title":"Mol Biol Evol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.06.025_bib0165","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/molbev\/msl051","article-title":"Automated phylogenetic detection of recombination using a genetic algorithm","volume":"23","author":"Kosakovsky Pond","year":"2006","journal-title":"Mol Biol Evol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2011.06.025_bib0170","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/JCM.00936-09","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales","volume":"47","author":"Lucidarme","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"May (21)","key":"10.1016\/j.vaccine.2011.06.025_bib0175","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.vaccine.2009.02.098","article-title":"Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus","volume":"27","author":"Bambini","year":"2009","journal-title":"Vaccine"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2011.06.025_bib0180","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.vaccine.2010.11.072","article-title":"Distribution of factor H binding protein beyond serogroup B: variation among five serogroups of invasive Neisseria meningitidis in South Africa","volume":"29","author":"Mothibeli","year":"2011","journal-title":"Vaccine"},{"issue":"November (45)","key":"10.1016\/j.vaccine.2011.06.025_bib0185","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.06.025_bib0190","series-title":"International Pathogenic Neisseria Conference","article-title":"Early clinical development of a novel, multicomponent meningococcal serogroup B vaccine (4CMenB)","author":"Dull","year":"2010"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2011.06.025_bib0195","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/656741","article-title":"Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy","volume":"51","author":"Findlow","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.06.025_bib0200","series-title":"International pathogenic neisseria conference","article-title":"Safety & immunogenicity of serogroup B Neisseria meningitidis (MnB) rLP2086 vaccine in adults and adolescent submects: overview of 3 clinical trials","author":"Richmond","year":"2010"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2011.06.025_bib0205","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2010.11.064","article-title":"Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1","volume":"29","author":"Brunelli","year":"2011","journal-title":"Vaccine"},{"issue":"August (37)","key":"10.1016\/j.vaccine.2011.06.025_bib0210","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.06.025_bib0215","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2009.12.027","article-title":"Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates","volume":"28","author":"Pajon","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.06.025_bib0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-60327-999-4_21","article-title":"Internet-based sequence-typing databases for bacterial molecular epidemiology","volume":"551","author":"Jolley","year":"2009","journal-title":"Methods Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11008899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T20:29:13Z","timestamp":1686169753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11008899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":44,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0264410X11008899"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}